IP Infustion
News/Events About Products Solutions Services Partners Support
 Home » News/Events » Press Release
 
 

 
 

Press Release

IP INFUSION SUCCESSFULLY PARTICIPATES IN THE NETWORLD+INTEROP 2002 LAS VEGAS MPLS INTEROPERABILITY INITIATIVE

May 29, 2002, San Jose, California - - IP Infusion Inc, a leading provider of intelligent network software for enhanced IP services, announced today that it participated in the NetWorld+Interop 2002 Las Vegas InteropNet Labs (iLabs) MPLS interoperability initiative on May 7-9th. IP Infusion tested its RSVP-TE, LDP, CSPF, and MPLS-VPN software and successfully interoperated with a number of leading communications equipment vendor implementations.

"NetWorld+Interop's iLabs MPLS interoperability program was an excellent forum to test and validate MPLS across a wide variety of vendor implementations. This kind of test environment is ideal to verify interoperability with key industry vendors before customers attempt to implement multiple vendor solutions," said Dr. Govind Desale, vice president of operations at IP Infusion. "IP Infusion was the only source code software supplier to participate in this interoperability initiative, and we successfully tested our entire MPLS product line."

The MPLS interoperability initiative allowed vendors to test against a number of leading MPLS solutions, including those from: Cisco, Juniper, Riverstone, Avici, Foundry Networks, Ixia, Extreme, and Unisphere. IP Infusion was one of a few vendors that provided RSVP-TE, CR-LDP, and CSPF solutions.

iLabs Built World's First Public Multivendor Implementation of IETF's Fast-Reroute Draft

MPLS can provide increased profitability and a competitive advantage for service providers by offering more flexibility in service provisioning. The NetWorld+Interop 2002 Las Vegas iLabs demonstrated that MPLS technology has matured to the point where it can support more scalable and sophisticated services, like point-to-multipoint VPNs, RSVP and Fast-Reroute traffic engineering. The iLabs MPLS Initiative showed networking professionals how MPLS can impact their enterprise networks and what is needed to leverage these services.

About IP Infusion's ZebOS™ Routing Suites

IP Infusion designs, develops, and markets its ZebOS™ family of advanced IP routing suites, which are based on a unique, modular, multi-process architecture featuring control-plane components that provide route redistribution and conversion, management services, and an OS/processor abstraction layer for routing and switching modules. This high-performance routing software features IPv4 and IPv6 versions of OSPF, BGP, and RIP routing protocols; MPLS, BGP-VPN, RSVP-TE, and CR-LDP switching and signaling protocols; and Mobile IP and virtual routing support. The ZebOS software suites can be delivered either as portable, platform-independent source code or in server solutions.

About IP Infusion

A leading provider of intelligent network software for enhanced IP services, IP Infusion is a developer of networking software that enables platforms, hardware, devices, and media across the Internet to communicate with each other openly and without dependence on specific technologies or platforms. Just as Unix and Windows are central to the PC and server markets, this leading edge software will drive the communication equipment market by providing the intelligence and manageability needed to develop equipment for creating enhanced IP services. IP Infusion was founded in 1999 and has more than 60 employees in its San Jose, California headquarters and elsewhere in the USA and Europe. The company has a growing global customer base in the wired and wireless networking markets and has alliances with the primary network processor (NPU) suppliers. IP Infusion is a member of the Network Processing Forum and an active participant in the IETF. For more information about the company and its products call 1-408-794-1500 or visit www.ipinfusion.com.


###

IP Infusion and ipinfusion are trademarks of IP Infusion Inc. All other brands or product names referenced in this release are trademarks or registered trademarks of their respective holders.